Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Understanding and appreciating overdiagnosis in the PSA era.

Literature DB >> 12096074

Understanding and appreciating overdiagnosis in the PSA era.

Siu-Long Yao, Grace Lu-Yao.

Abstract

Mesh：

Substances：

Year: 2002 PMID： 12096074 DOI： 10.1093/jnci/94.13.958

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Authors: Vickie L Shavers; Martin L Brown; Arnold L Potosky; Carrie N Klabunde; W W Davis; Judd W Moul; Angela Fahey
Journal: J Gen Intern Med Date: 2004-02 Impact factor: 5.128

Review 2. Screening for cancer: valuable or not?

Authors: Frank L Meyskens
Journal: Curr Oncol Rep Date: 2004-11 Impact factor: 5.075

3. Prostate-specific antigen testing among the elderly in community-based family medicine practices.

Authors: Shawna V Hudson; Pamela Ohman-Strickland; Jeanne M Ferrante; Grace Lu-Yao; A John Orzano; Benjamin F Crabtree
Journal: J Am Board Fam Med Date: 2009 May-Jun Impact factor: 2.657

4. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.

Authors: Lisa F Newcomb; James D Brooks; Peter R Carroll; Ziding Feng; Martin E Gleave; Peter S Nelson; Ian M Thompson; Daniel W Lin
Journal: Urology Date: 2009-09-16 Impact factor: 2.649

Review 5. DNA methylation changes in prostate cancer: current developments and future clinical implementation.

Authors: Mohammad Obaidul Hoque
Journal: Expert Rev Mol Diagn Date: 2009-04 Impact factor: 5.225

6. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Authors: Kathryn L Taylor; Richard M Hoffman; Kimberly M Davis; George Luta; Amethyst Leimpeter; Tania Lobo; Scott P Kelly; Jun Shan; David Aaronson; Catherine A Tomko; Amy J Starosta; Charlotte J Hagerman; Stephen K Van Den Eeden
Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-06-02 Impact factor: 4.254

Understanding and appreciating overdiagnosis in the PSA era.

1. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Review 2. Screening for cancer: valuable or not?

3. Prostate-specific antigen testing among the elderly in community-based family medicine practices.

4. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.

Review 5. DNA methylation changes in prostate cancer: current developments and future clinical implementation.

6. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

7. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

8. Construction of tissue microarrays from prostate needle biopsy specimens.

9. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.

10. Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.